New brain scans track repair and damage in MS lesions

Credibility

Interest

Share:1 min read

Key Takeaway

Detailed brain scans found signs of both repair and damage in MS lesions over two years.

What They Found

Researchers used detailed brain scans to track changes in MS lesions over two years. Stable lesions were the largest group, making up about 44% of those studied. About 26% showed signs of repair, while about 24% showed signs of damage. People with more lesions showing repair had less disability at the follow-up visit. Lesions showing damage were more common in people with progressive MS than in people with relapsing-remitting MS.

Who Should Care and Why

The study included people with relapsing-remitting or progressive MS, as well as people without MS. The lesion findings came from the people with MS. They show that signs of repair and damage can appear across the forms of MS studied. People with progressive MS had more lesions showing damage than those with relapsing-remitting MS. The scans also linked lesion patterns with disability and age.

Important Considerations

You should know this study observed 128 people with MS and 72 people without MS; it did not test a treatment. Researchers scanned them at the start and two years later. The scans showed patterns linked with disability, but they do not show that repair caused less disability.

AI-generated summary — for informational purposes only, not medical advice

Categories:

MS Diagnostics MS Progression

Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Annals of neurology often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.

However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.

By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.

Back to News